JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 2.200
+0.010 (0.46%)
Sep 18, 2026, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 892.97 million as of September 18, 2026. Its market cap has decreased by -55.43% in one year.
Market Cap
892.97M
Enterprise Value
734.58M
Revenue
333.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
ChartMarket Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 892.97M, a decrease of -89.21%. That is a compound annual growth rate of -31.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 892.97M | -12.30% |
| Dec 31, 2025 | 1.02B | 96.55% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.37B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.35B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.30B |
| TYK Medicines | 1.25B |
| CANbridge Pharmaceuticals | 1.20B |
| Cloudbreak Pharma | 1.01B |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 898.73M |